Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calithera Biosciences IncfiledCriticalCalithera Biosciences Inc
Priority claimed from PCT/US2017/068307external-prioritypatent/WO2018119440A1/en
Publication of MA47097B1publicationCriticalpatent/MA47097B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne une nouvelle classe de composés présentant une activité inhibitrice vis-à-vis de l'arginase et des compositions pharmaceutiques comprenant les composés de l'invention. L'invention concerne également des procédés de traitement du cancer à l'aide des inhibiteurs de l'arginase de la présente invention.The invention relates to a novel class of compounds exhibiting inhibitory activity against arginase and pharmaceutical compositions comprising the compounds of the invention. Also provided are methods of treating cancer using the arginase inhibitors of the present invention.
MA47097A2016-12-222017-12-22
Compositions and methods for inhibiting arginase activity
MA47097B1
(en)